Danazol in the treatment of benign breast disease.
article
OA: closed
CC0
⤵ 8 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This paper investigated the efficacy of danazol in treating benign breast disease.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
Cited by (8)
- Ultrastructural Features of Danazol-Induced Cholestasis: A Case Study 1996
- Postmenopausal endometrial hyperplasia: role of danazol therapy 1994
- Treatment of recurrent cyclical mastodynia in patients with fibrocystic breast disease 1984
- Danazol treatment of severely symptomatic fibrocystic breast disease and long‐term follow‐up—the Hjørring project 1984
- Progestin-Like Effects of Danazol on Rabbit Uterus* 1983
- Successful treatment of D-penicillamine-induced breast gigantism with danazol. 1981
- Successful treatment of D-penicillamine-induced breast gigantism with danazol. 1981
- Danazol for benign breast disease 1980
Source provenance
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0
· commercial use OK